Citicoline is unusual in the focus category: unlike a cumulative botanical such as bacopa, it has evidence pointing at two different timescales: an acute, same-day effect on attention and a longer, weeks-long effect on memory. That makes "how long does it take to work?" genuinely answerable, with the honest caveat that both halves of the evidence share the same limitation.

This article is educational and is not medical advice. Supplements are not intended to diagnose, treat, cure, or prevent any disease. Talk to a qualified clinician before starting anything new. Health Canada's monograph says to ask a health care practitioner before using citicoline if you are pregnant or breastfeeding, take dopaminergic or cholinergic drugs, or have ADD or ADHD.

The two timescales

Some citicoline trials measured effects within a single dosing period. In a randomized, placebo-controlled study in healthy women, 28 days of citicoline (250 mg and 500 mg/day) reduced attention lapses (commission errors on a sustained-attention test) versus placebo (McGlade 2012). That points to an attention benefit you might reasonably expect over days-to-weeks, not months. Separately, a randomized trial in healthy older adults found that 500 mg/day over 12 weeks improved episodic memory measures versus placebo (Nakazaki 2021). So the practical read: attention effects appear on the shorter end; the memory evidence is a multi-week, daily-use story.

A realistic expectation

  • Days to a few weeks: the attention/focus evidence sits here. The sustained-attention benefit was measured over a 28-day window, so give it consistent daily use rather than judging a single dose.
  • 8–12 weeks: the memory evidence sits here. The episodic-memory improvement was measured at 12 weeks of daily dosing.
  • Either way, daily and consistent: citicoline is positioned as a daily-use ingredient in the trials, not a take-it-when-you-need-it stimulant.

The caveat that applies to both findings

Both principal supporting trials are tied to the manufacturer of the branded citicoline form (Cognizin, from Kyowa Hakko Bio). That sponsor dependence is one reason we now grade citicoline C rather than B. The independent healthy-adult research is smaller and narrower than the marketing: an academically funded crossover trial (Knott 2015) improved cognition only in people who started as low performers, and reduced it in high performers. Independent review has gone the other way too. EFSA's 2024 opinion on a proposed citicoline memory claim found no established cause-and-effect relationship, and large trials in stroke and brain-injury patients were null, one of them funded by a citicoline manufacturer, the other by the US National Institutes of Health. It's not a reason to dismiss citicoline. It's a reason to hold the expectation at "plausible, limited evidence" rather than "proven."

Get The Signal by email. New research, grade changes and safety notes, about every two weeks. Subscribe free

Dose and form

  • Studied dose: 250–500 mg per day in the trials above.
  • Form: check the elemental citicoline dose per serving; branded forms should be named and dosed transparently rather than buried in a proprietary blend.
  • Don't stack redundantly: combining multiple high-dose choline sources without a specific rationale adds cost, not obviously benefit.

The bottom line

Expect any attention benefit on the shorter timescale (over days to a few weeks of consistent daily use), and treat the memory benefit as a 12-week, daily-use proposition. Both rest on manufacturer-linked trials, so keep expectations modest, and give it consistent daily dosing at 250–500 mg rather than judging it on a single day. If you want the head-to-head with the other main choline donor, see our citicoline versus alpha-GPC comparison.

References

This article draws on the primary human research below; see the linked studies for full methods and doses.

  • McGlade E, Locatelli A, Hardy J, et al. "Improved Attentional Performance Following Citicoline Administration in Healthy Adult Women." Food and Nutrition Sciences, 2012;3(6):769–773.
  • Nakazaki E, Mah E, Sanoshy K, et al. "Citicoline and Memory Function in Healthy Older Adults: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial." The Journal of Nutrition, 2021;151(8):2153–2160. PMID: 33978188.
  • Turck D, Bohn T, Castenmiller J, et al. (EFSA NDA Panel). "'Citicoline' and support of the memory function: Evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006." EFSA Journal, 2024;22(7):e8861. PMID: 38966137.
  • Zafonte RD, Bagiella E, Ansel BM, et al. "Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: Citicoline Brain Injury Treatment Trial (COBRIT)." JAMA, 2012;308(19):1993–2000. PMID: 23168823.
  • Knott V, de la Salle S, Choueiry J, et al. "Neurocognitive effects of acute choline supplementation in low, medium and high performer healthy volunteers." Pharmacology, Biochemistry and Behavior, 2015. PMID: 25681529.
  • Spiers PA, Myers D, Hochanadel GS, et al. "Citicoline improves verbal memory in aging." Archives of Neurology, 1996;53(5):441–448. PMID: 8624220.